Hyperparathyroidism and Asthenia. A New Deal?

Abstract

The profile of primary hyperparathyroidism (PHPT) changed profoundly over the course of the twentieth century. The highly symptomatic forms reported in the 1960s have progressively been replaced by forms with few symptoms and in some cases totally asymptomatic forms. As of 1991, with the increasing frequency of these new forms, several consensus meetings designed to define the criteria for establishing the operability of minimally-symptomatic hyperparathyroidism have been organized [1].

Authors and Affiliations

Sun Fui S Li, Bonnichon P

Keywords

Related Articles

Dipeptidyl Peptidase IV Inhibitory Activity of Berberine and Mangiferin: An In Silico Approach

Background: Dipeptidyl peptidase-IV (DDP-IV) Inhibitors may represent single anti-diabetic drugs, the multiple actions of which may translate into demonstrable therapeutic benefits in diabetes. The marketed synthetic DPP...

Clinical Aspects of C-Type Natriuretic Peptide on the Cardiovascular System

C-type natriuretic peptide (CNP) is one of the three most important members of the human natriuretic peptide family, sharing with them a highly conserved 17-aminoacid ring structure, essential to elicit its biological ac...

The Importance of Risk Stratification and Management of Newborn Babies of Women with a History of Graves’ disease

Thyroid hormones are important for early brain development. During pregnancy, both maternal and foetal thyroid hormones contribute to foetal brain development. Maternal Graves’ can lead to transplacental transfer of anti...

Congenital Generalized Lipodystrophy: A Multisystemic Metabolic Disorder

Introduction: Congenital generalized lipodystrophy or Berardinelli-Seip syndrome is a rare autosomal recessive multisystem disorder characterized by the near absence of subcutaneous and visceral adipose tissue from birth...

Parathyroid adenoma-An incidental diagnosis

A 50 year old man was referred to us with inadequate control of blood pressure for last few years. He was being treated as a case of essential hypertension on a four drug regime. Subsequent work up led to the diagnosis o...

Download PDF file
  • EP ID EP542530
  • DOI 10.17352/ijcem.000028
  • Views 50
  • Downloads 0

How To Cite

Sun Fui S Li, Bonnichon P (2017). Hyperparathyroidism and Asthenia. A New Deal?. International Journal of Clinical Endocrinology and Metabolism, 3(1), 46-47. https://europub.co.uk/articles/-A-542530